“In a Prospective, Multicenter Study, the 31-GEP Identified Patients at Increased Risk of Tumor Recurrence and Added Significant Prognostic Value to AJCC Staging”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s504. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/3058.